MedTrace Logo

Predictors of Treatment Failure Among Patients With Gunshot Wounds and Post-traumatic Stress Disorder

NCT04689022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2020-12-30

No results posted yet for this study

Summary

The 82.1% treatment failure of post-traumatic stress disorder(PTSD), associated with gunshot wounds, is related to high incidence of chronic pain syndrome as well as resistance to the PTSD treatment. Defining treatment failure predictors among the PTSD patients with gunshot extremity wounds and the following therapy would improve treatment outcomes.

Conditions

  • Gunshot Entry Wound

Interventions

BEHAVIORAL

Mississippi Scale for Combat-Related PTSD (M-PTSD)

The treatment outcome rate was assessed by the Mississippi Scale for Combat-Related PTSD (M-PTSD). A positive outcome rate is represented with the patient post-discharge positive coping, which corresponds to 94-58 points, observed in 39 patients (17.9%). A treatment failure is regarded as the absent PTSD treatment effect after discharge, which corresponds to 148-113 points, observed in 5 patients (2.3%) and psychic disorders, which correspond to 112-95 points, observed in 174 patients (79,8%).

DIAGNOSTIC_TEST

visual analogue scale (VAS)

pain intensity

DIAGNOSTIC_TEST

Douleur Neuropathique 4 questions (DN4)

neuropathic pain component

Sponsors & Collaborators

  • Bogomolets National Medical University

    collaborator OTHER

  • Vasyl' Horoshko

    lead OTHER

Principal Investigators

  • Iurii Kuchyn, MD · National medical University named after O. O. Bogomolets, Kyiv, Ukraine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2019-12-30
Completion
2020-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689022 on ClinicalTrials.gov